Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| REKOVELLE | FERRING INC | Actual shortage | 36MCG | Updated Report | 2020-12-01 | 101018 |
| REKOVELLE | FERRING INC | Actual shortage | 12MCG | Updated Report | 2020-12-01 | 101024 |
| REKOVELLE | FERRING INC | Actual shortage | 72MCG | Updated Report | 2020-12-01 | 101003 |
| DURATOCIN | FERRING INC | Actual shortage | 100MCG | Updated Report | 2020-12-01 | 129238 |
| ARAVA 20 MG | SANOFI-AVENTIS CANADA INC | Actual shortage | 20MG | Updated Report | 2020-12-01 | 128414 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | PURDUE PHARMA | Anticipated shortage | 18MG | New Report | 2020-12-01 | 129224 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | PURDUE PHARMA | Resolved | 18MG | Updated Report | 2020-12-01 | 127123 |
| DILAUDID | PURDUE PHARMA | Actual shortage | 8MG | Updated Report | 2020-12-01 | 127120 |
| APO-TADALAFIL | APOTEX INC | Actual shortage | 5MG | Updated Report | 2020-12-01 | 127376 |
| APO-RAMIPRIL | APOTEX INC | Actual shortage | 2.5MG | Updated Report | 2020-12-01 | 127754 |
| APO-LISINOPRIL TABLET 5 MG | APOTEX INC | Actual shortage | 5MG | Updated Report | 2020-12-01 | 126292 |
| APO-LISINOPRIL TABLET 20 MG | APOTEX INC | Actual shortage | 20MG | Updated Report | 2020-12-01 | 128606 |
| APO IBUPROFEN TAB 400MG | APOTEX INC | Actual shortage | 400MG | Updated Report | 2020-12-01 | 126283 |
| APO IBUPROFEN TAB 400MG | APOTEX INC | Actual shortage | 400MG | Updated Report | 2020-12-01 | 77890 |
| ISOPTIN SR | BGP PHARMA ULC | Actual shortage | 120MG | Updated Report | 2020-12-01 | 118074 |
| TEVETEN | BGP PHARMA ULC | Anticipated shortage | 400MG | New Report | 2020-12-01 | 129203 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 150MCG | Updated Report | 2020-12-01 | 124241 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 100MCG | Updated Report | 2020-12-01 | 126687 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 88MCG | New Report | 2020-12-01 | 129196 |
| SYNTHROID | BGP PHARMA ULC | Anticipated shortage | 25MCG | New Report | 2020-12-01 | 129193 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | Discontinued | 20MG | Updated Report | 2020-12-01 | 68392 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | Discontinued | 40MG | Updated Report | 2020-12-01 | 68395 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | To be discontinued | 40MG | New Report | 2020-11-30 | 129134 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | To be discontinued | 20MG | New Report | 2020-11-30 | 129131 |
| AVANDIA | GLAXOSMITHKLINE INC | Discontinued | 4MG | Updated Report | 2020-11-27 | 113314 |
| LOPRESOR SR 100MG | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 100MG | New Report | 2020-11-26 | 128967 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | BAXTER CORPORATION | To be discontinued | 5G 900MG 300MG | New Report | 2020-11-26 | 128947 |
| IMURAN | ASPEN PHARMACARE CANADA INC. | To be discontinued | 50MG | New Report | 2020-11-20 | 128667 |
| LEVITRA | BAYER INC | Discontinued | 5MG | Updated Report | 2020-11-20 | 121585 |
| HUMIRA | ABBVIE CORPORATION | Discontinued | 40MG | Updated Report | 2020-11-19 | 119141 |
| CLINIMIX E | BAXTER CORPORATION | To be discontinued | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | Updated Report | 2020-11-18 | 118604 |
| CLINIMIX | BAXTER CORPORATION | To be discontinued | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | Updated Report | 2020-11-18 | 118601 |
| CLINIMIX E | BAXTER CORPORATION | To be discontinued | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | Updated Report | 2020-11-18 | 118607 |
| CLINIMIX | BAXTER CORPORATION | To be discontinued | 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG | Updated Report | 2020-11-18 | 118612 |
| APO-BRIMONIDINE | APOTEX INC | Discontinued | 0.2% | New Report | 2020-11-16 | 128438 |
| LOPRESOR SR 100MG | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 100MG | Updated Report | 2020-11-13 | 128056 |
| DOM-CIPROFLOXACIN | DOMINION PHARMACAL | Discontinued | 500MG | New Report | 2020-11-13 | 128343 |
| TALWIN | SANOFI-AVENTIS CANADA INC | To be discontinued | 50MG | Updated Report | 2020-11-09 | 128146 |
| LOPRESOR SR 100MG | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 100MG | Updated Report | 2020-11-07 | 128052 |
| LOPRESOR SR 200 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 200MG | Updated Report | 2020-11-07 | 128059 |
